Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orchiopexy | 1 | 2025 | 2 | 0.950 |
Why?
|
| Acer | 1 | 2025 | 1 | 0.950 |
Why?
|
| Plant Poisoning | 1 | 2025 | 2 | 0.940 |
Why?
|
| Cryptorchidism | 1 | 2025 | 37 | 0.930 |
Why?
|
| Horse Diseases | 1 | 2025 | 35 | 0.920 |
Why?
|
| Laparoscopy | 5 | 2025 | 541 | 0.890 |
Why?
|
| Muscular Diseases | 1 | 2025 | 124 | 0.860 |
Why?
|
| Testis | 1 | 2025 | 398 | 0.800 |
Why?
|
| Carcinoma, Renal Cell | 9 | 2006 | 222 | 0.770 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2023 | 39 | 0.760 |
Why?
|
| Bacteriuria | 1 | 2023 | 81 | 0.720 |
Why?
|
| Kidney Neoplasms | 10 | 2006 | 420 | 0.700 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2023 | 126 | 0.690 |
Why?
|
| Vesico-Ureteral Reflux | 5 | 2023 | 79 | 0.610 |
Why?
|
| Ureteral Obstruction | 4 | 2023 | 92 | 0.590 |
Why?
|
| Urinary Tract Infections | 1 | 2023 | 328 | 0.570 |
Why?
|
| Ureteroscopy | 3 | 2025 | 17 | 0.560 |
Why?
|
| Ureter | 4 | 2023 | 85 | 0.530 |
Why?
|
| Cryosurgery | 4 | 2005 | 51 | 0.530 |
Why?
|
| Nephrectomy | 4 | 2018 | 156 | 0.500 |
Why?
|
| Kidney Pelvis | 3 | 2021 | 34 | 0.440 |
Why?
|
| Kidney Calculi | 2 | 2025 | 40 | 0.440 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 214 | 0.410 |
Why?
|
| Hypospadias | 3 | 2020 | 76 | 0.400 |
Why?
|
| Kidney | 2 | 2016 | 1283 | 0.370 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 2008 | 31 | 0.320 |
Why?
|
| Neonatal Screening | 3 | 2008 | 201 | 0.320 |
Why?
|
| Urology | 2 | 2018 | 80 | 0.310 |
Why?
|
| Serum | 1 | 2010 | 43 | 0.310 |
Why?
|
| Blood Specimen Collection | 1 | 2010 | 47 | 0.310 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 81 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 2107 | 0.300 |
Why?
|
| Carbon | 1 | 2010 | 99 | 0.300 |
Why?
|
| Prostate | 2 | 2017 | 410 | 0.300 |
Why?
|
| Urethral Diseases | 2 | 2020 | 15 | 0.280 |
Why?
|
| Infant | 17 | 2025 | 13269 | 0.280 |
Why?
|
| Postoperative Complications | 5 | 2023 | 3112 | 0.280 |
Why?
|
| Child | 19 | 2025 | 26165 | 0.280 |
Why?
|
| Retrospective Studies | 16 | 2025 | 17614 | 0.270 |
Why?
|
| Bile Acids and Salts | 1 | 2010 | 259 | 0.260 |
Why?
|
| Cortodoxone | 1 | 2007 | 4 | 0.260 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2007 | 9 | 0.260 |
Why?
|
| Penis | 2 | 2020 | 83 | 0.260 |
Why?
|
| Treatment Outcome | 13 | 2025 | 12860 | 0.240 |
Why?
|
| Hypoglycins | 1 | 2025 | 1 | 0.240 |
Why?
|
| Ureteral Calculi | 1 | 2025 | 5 | 0.230 |
Why?
|
| Horses | 1 | 2025 | 93 | 0.230 |
Why?
|
| Nephrolithotomy, Percutaneous | 1 | 2025 | 5 | 0.230 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2005 | 7 | 0.230 |
Why?
|
| Lithotripsy | 1 | 2025 | 22 | 0.230 |
Why?
|
| Child, Preschool | 14 | 2025 | 14985 | 0.230 |
Why?
|
| Kidney Transplantation | 2 | 2023 | 562 | 0.220 |
Why?
|
| Catheter Ablation | 2 | 2005 | 320 | 0.210 |
Why?
|
| Documentation | 2 | 2022 | 120 | 0.200 |
Why?
|
| Humans | 41 | 2025 | 130422 | 0.200 |
Why?
|
| Male | 28 | 2025 | 64527 | 0.200 |
Why?
|
| Urologic Neoplasms | 1 | 2003 | 30 | 0.200 |
Why?
|
| Urinalysis | 1 | 2023 | 74 | 0.190 |
Why?
|
| Hydronephrosis | 3 | 2021 | 34 | 0.180 |
Why?
|
| Penile Diseases | 1 | 2020 | 10 | 0.170 |
Why?
|
| Urinary Fistula | 1 | 2020 | 14 | 0.170 |
Why?
|
| Cutaneous Fistula | 1 | 2020 | 21 | 0.170 |
Why?
|
| Hospitals, Pediatric | 3 | 2020 | 802 | 0.160 |
Why?
|
| Reoperation | 3 | 2020 | 832 | 0.160 |
Why?
|
| Anesthetics | 1 | 2020 | 77 | 0.150 |
Why?
|
| Urologic Surgical Procedures | 4 | 2021 | 57 | 0.150 |
Why?
|
| Nerve Block | 1 | 2020 | 69 | 0.150 |
Why?
|
| Urogenital System | 1 | 2019 | 34 | 0.150 |
Why?
|
| Adolescent | 11 | 2025 | 20754 | 0.140 |
Why?
|
| Equipment Design | 2 | 2018 | 541 | 0.140 |
Why?
|
| Child Health | 1 | 2019 | 66 | 0.140 |
Why?
|
| Pediatricians | 1 | 2019 | 75 | 0.140 |
Why?
|
| Physical Examination | 1 | 2019 | 160 | 0.140 |
Why?
|
| Anesthesia | 1 | 2020 | 211 | 0.140 |
Why?
|
| Pediatrics | 2 | 2018 | 1244 | 0.140 |
Why?
|
| Physicians, Women | 1 | 2018 | 53 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2010 | 289 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 771 | 0.130 |
Why?
|
| Prostatic Diseases | 1 | 2017 | 13 | 0.130 |
Why?
|
| Engineering | 1 | 2017 | 7 | 0.130 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2016 | 16 | 0.130 |
Why?
|
| Female | 21 | 2025 | 70285 | 0.120 |
Why?
|
| Hematuria | 1 | 2016 | 48 | 0.120 |
Why?
|
| Spermatic Cord Torsion | 1 | 2016 | 16 | 0.120 |
Why?
|
| Cystitis | 1 | 2016 | 47 | 0.120 |
Why?
|
| Abscess | 1 | 2017 | 136 | 0.120 |
Why?
|
| Operating Rooms | 1 | 2016 | 74 | 0.120 |
Why?
|
| Urethra | 1 | 2015 | 58 | 0.120 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 90 | 0.120 |
Why?
|
| Carbonic Anhydrases | 2 | 2006 | 21 | 0.120 |
Why?
|
| Injury Severity Score | 1 | 2016 | 233 | 0.110 |
Why?
|
| Foreskin | 1 | 2015 | 4 | 0.110 |
Why?
|
| Patient Transfer | 1 | 2016 | 110 | 0.110 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 324 | 0.110 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 153 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2016 | 351 | 0.110 |
Why?
|
| Hydrocolpos | 1 | 2014 | 2 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2022 | 812 | 0.110 |
Why?
|
| Infant, Newborn | 8 | 2018 | 8493 | 0.110 |
Why?
|
| Skin Transplantation | 1 | 2015 | 56 | 0.110 |
Why?
|
| Ureterocele | 1 | 2014 | 3 | 0.110 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 230 | 0.110 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 159 | 0.110 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 222 | 0.100 |
Why?
|
| Bone Marrow Transplantation | 1 | 2016 | 590 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 2546 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 701 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 251 | 0.100 |
Why?
|
| Models, Animal | 2 | 2005 | 455 | 0.100 |
Why?
|
| Surgical Flaps | 1 | 2015 | 180 | 0.100 |
Why?
|
| Ultrasonic Therapy | 2 | 2003 | 27 | 0.090 |
Why?
|
| Incidence | 5 | 2020 | 3330 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 563 | 0.090 |
Why?
|
| Chromatography, Liquid | 2 | 2010 | 237 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1031 | 0.080 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2003 | 194 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2022 | 813 | 0.080 |
Why?
|
| Animals | 4 | 2025 | 33892 | 0.080 |
Why?
|
| Galactosemias | 1 | 2010 | 14 | 0.080 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2010 | 38 | 0.080 |
Why?
|
| Peroxisomal Disorders | 1 | 2010 | 17 | 0.080 |
Why?
|
| Operative Time | 2 | 2020 | 199 | 0.070 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 2008 | 1 | 0.070 |
Why?
|
| Linear Models | 1 | 2010 | 688 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1205 | 0.070 |
Why?
|
| Androstenedione | 1 | 2007 | 15 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2016 | 3682 | 0.060 |
Why?
|
| Calibration | 1 | 2007 | 92 | 0.060 |
Why?
|
| Wound Healing | 2 | 2015 | 476 | 0.060 |
Why?
|
| False Positive Reactions | 1 | 2007 | 143 | 0.060 |
Why?
|
| Biliary Atresia | 1 | 2010 | 220 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 325 | 0.060 |
Why?
|
| Hydrocortisone | 1 | 2007 | 217 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2022 | 1223 | 0.060 |
Why?
|
| Kidney Calices | 1 | 2005 | 4 | 0.060 |
Why?
|
| Kidney Cortex | 1 | 2005 | 19 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3425 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2025 | 6423 | 0.060 |
Why?
|
| United States | 4 | 2025 | 11827 | 0.060 |
Why?
|
| Needles | 1 | 2005 | 49 | 0.060 |
Why?
|
| Oxidoreductases | 1 | 2005 | 105 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2005 | 141 | 0.050 |
Why?
|
| Necrosis | 1 | 2005 | 194 | 0.050 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2004 | 25 | 0.050 |
Why?
|
| Safety | 1 | 2005 | 213 | 0.050 |
Why?
|
| Young Adult | 3 | 2025 | 9995 | 0.050 |
Why?
|
| Canada | 1 | 2025 | 322 | 0.050 |
Why?
|
| Surgeons | 2 | 2020 | 289 | 0.050 |
Why?
|
| Time Factors | 2 | 2015 | 6190 | 0.050 |
Why?
|
| Dogs | 1 | 2005 | 615 | 0.050 |
Why?
|
| Cysts | 1 | 2004 | 88 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 35 | 0.050 |
Why?
|
| Prognosis | 5 | 2016 | 4894 | 0.050 |
Why?
|
| Syphilis, Congenital | 1 | 2003 | 32 | 0.050 |
Why?
|
| Survival Rate | 4 | 2016 | 2131 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2005 | 212 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2020 | 5069 | 0.050 |
Why?
|
| Laser Therapy | 1 | 2005 | 241 | 0.050 |
Why?
|
| Quality Improvement | 2 | 2020 | 698 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2003 | 265 | 0.050 |
Why?
|
| Cancer Vaccines | 1 | 2004 | 190 | 0.050 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2003 | 67 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 471 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 227 | 0.040 |
Why?
|
| Monocytes | 1 | 2004 | 336 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2007 | 852 | 0.040 |
Why?
|
| Swine | 1 | 2005 | 1184 | 0.040 |
Why?
|
| Fatty Acid Desaturases | 1 | 2001 | 13 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2005 | 492 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2004 | 583 | 0.040 |
Why?
|
| Training Support | 1 | 2020 | 20 | 0.040 |
Why?
|
| Nurse Anesthetists | 1 | 2020 | 14 | 0.040 |
Why?
|
| Sacrococcygeal Region | 1 | 2020 | 36 | 0.040 |
Why?
|
| Anesthesia, Caudal | 1 | 2020 | 15 | 0.040 |
Why?
|
| Anesthesiologists | 1 | 2020 | 43 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 2919 | 0.040 |
Why?
|
| Neoplasm Staging | 4 | 2004 | 1300 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2003 | 495 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2020 | 141 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2001 | 125 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 2019 | 34 | 0.040 |
Why?
|
| Patient Selection | 1 | 2003 | 721 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2022 | 400 | 0.040 |
Why?
|
| Recurrence | 2 | 2018 | 1482 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 473 | 0.040 |
Why?
|
| Dextrans | 1 | 2018 | 43 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 249 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 315 | 0.030 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 108 | 0.030 |
Why?
|
| Texas | 2 | 2016 | 3626 | 0.030 |
Why?
|
| Career Choice | 1 | 2018 | 165 | 0.030 |
Why?
|
| Administration, Intravesical | 1 | 2016 | 30 | 0.030 |
Why?
|
| Mentors | 1 | 2018 | 161 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 1276 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 147 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 28 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 1606 | 0.030 |
Why?
|
| Cicatrix | 1 | 2018 | 125 | 0.030 |
Why?
|
| Cystoscopy | 1 | 2016 | 41 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 5186 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 76 | 0.030 |
Why?
|
| Program Development | 1 | 2017 | 179 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 4656 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 259 | 0.030 |
Why?
|
| Mentoring | 1 | 2017 | 83 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 555 | 0.030 |
Why?
|
| Triage | 1 | 2016 | 144 | 0.030 |
Why?
|
| Colpotomy | 1 | 2014 | 7 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 503 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 372 | 0.030 |
Why?
|
| Health Facilities | 1 | 2014 | 66 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 1344 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 583 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2017 | 279 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 1543 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2003 | 1395 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 1683 | 0.020 |
Why?
|
| Germany | 2 | 2003 | 57 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 774 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2004 | 900 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2016 | 1452 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 10942 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 575 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2020 | 1215 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1229 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 2205 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 850 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2847 | 0.020 |
Why?
|
| Middle Aged | 5 | 2005 | 28383 | 0.020 |
Why?
|
| Carbonic Anhydrase IX | 1 | 2006 | 5 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 974 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2004 | 13 | 0.010 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2003 | 15 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 202 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2004 | 307 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 781 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3815 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 356 | 0.010 |
Why?
|
| Aged | 3 | 2005 | 20894 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 1019 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 767 | 0.010 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2001 | 6 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 1004 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2003 | 412 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2003 | 482 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2003 | 628 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1607 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 1498 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2004 | 902 | 0.010 |
Why?
|
| Adult | 3 | 2005 | 31127 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2004 | 753 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 1335 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 1680 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3715 | 0.010 |
Why?
|
| Mass Screening | 1 | 2001 | 805 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 1710 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 4474 | 0.010 |
Why?
|
| Mutation | 1 | 2008 | 6131 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 6781 | 0.010 |
Why?
|
| Mice | 1 | 2006 | 18188 | 0.000 |
Why?
|